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Neural stem cellWe recently reported that young (3 to 4 months old) mice lacking Exon 1 of the Smad7 gene (S7ΔEx1 mice)
show enhanced proliferation of neural stem and progenitor cells (NPCs) in the hippocampal dentate gyrus
(DG) and in the subventricular zone (SVZ) of the lateral ventricles. It remained unclear, however, whether this
phenotype would persist along aging, the latter typically being associated with a profound decrease in
neurogenesis. Analysis of NPCs' proliferation based on the cell cycle marker PCNA in 12 month-old S7ΔEx1
mice revealed a reversal of the phenotype. Hence, in contrast to their younger counterparts, 12 month-old
S7ΔEx1 mice had a reduced number of proliferating cells, compared to wildtype (WT) mice. At the same time,
the survival of newly generated cells was enhanced in the aged transgenic animals. 12 month-old S7ΔEx1
mice further displayed a reduced level of neurogenesis based on the numbers of cells expressing doublecortin
(DCX), a marker for newborn neurons. The reduced neurogenesis in aged S7ΔEx1 mice was not due to a stem
cell depletion, which might have occurred as a consequence of hyperproliferation in the young mice, since the
number of Nestin and Sox2 positive cells was similar in WT and S7ΔEx1 mice. Instead, Nestin positive cells in
the DG as well as primary neurosphere cultures derived from 12 month-old S7ΔEx1 mice had a reduced
capability to proliferate. However, after passaging, when released from their age- and niche-associated
proliferative block, neurospheres from aged S7ΔEx1 mice regained the hyperproliferative property. Further,
pSmad2 antibody staining intensity was elevated in the DG and SVZ of 12-month old transgenic compared to
WTmice, indicating increased intracellular TGF-beta signaling in the aged S7ΔEx1mice. In summary, this points
toward differential effects of S7ΔEx1 on neurogenesis: (i) a hyperproliferation in young animals caused by a cell
autonomous mechanism, and (ii) a TGF-beta dependent modulation of neurogenesis in aged S7ΔEx1 animals
that abrogates the cell-intrinsic hyperproliferative properties and results in reduced proliferation, increased
stem cell quiescence, and enhanced survival of newly generated cells.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The existence of adult neurogenesis, i.e. the generation of new
neurons, in the CNS of most mammals including human is nowadays
widely recognized (Altman and Das, 1965; Eriksson et al., 1998;
Spalding et al., 2013). However, the rates of neurogenesis are not static
and have been shown to be dramatically diminished in aged animals.enerative Medicine, Paracelsus
ia. Tel.: +43 662 2420 80 800;
. This is an open access article underAging typically leads to a more than 100-fold reduction of neurogenesis
rates in aged compared to young adult brains (Kuhn et al., 1996). Such
modulations or defects in neurogenesis might be implicated in age-
related cognitive impairments, in neurodegenerative diseases or in
neuropsychiatric diseases such as depression (Couillard-Despres et al.,
2009; Drapeau et al., 2003; Kandasamy et al., 2010; Mirescu and Gould,
2006). Vice versa, stimulation of neurogenesis could provide additional
new neurons in aged or degenerated brains and thereby maintain/re-
store structures and functions (Ming and Song, 2005). Thus, molecular
mechanisms regulating neurogenesis in the adult healthy or diseased
brain might become therapeutic targets for CNS repair.
Unfortunately, the mechanisms responsible for the age-dependent
decline of neurogenesis are not fully deciphered. Reduction ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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liferation, which get locked into a quiescent state. Evidence supporting
this hypothesis comes from preliminary studies suggesting that neural
stem cell numbers remain constant within the hippocampus during
aging (Bonaguidi et al., 2011; Hattiangady and Shetty, 2008).
Alternatively, the stemcell poolmight get depletedover time, a possibility
that cannot be excluded at present. Indeed, more recent data suggest that
themassive fall in neurogenesis occurring along agingmight be caused by
an exhaustion of the stem cell pool (Encinas et al., 2011; Yu et al., 2010).
Nevertheless, progenitor cell proliferation in the aged brain can be
reactivated by physical activity, by the dilution of blood-born factors, or
by pharmacological treatment using for example G-CSF (Kempermann
et al., 1998; Popa-Wagner et al., 2010; Villeda et al., 2011). Further, inhi-
bition of elevated TGF-beta signaling, which is known to suppress neural
stem and progenitor cell proliferation (Wachs et al., 2006), re-induces
neurogenesis in the aged brain (Pineda et al., 2013).
We recently showed that young (3–4 months old) adult mice lack-
ing Exon 1 of Smad7, an inhibitor of TGF-beta and BMP signaling,
(S7ΔEx1mice) bear enhanced proliferation of neural stem and progen-
itor cells (NPCs) in the dentate gyrus (DG) and the subventricular zone
(SVZ) in a TGF-beta independent manner. In the present study, we in-
vestigated whether this phenotype would persist along aging, the latter
being typically associated with profound decrease in neurogenesis. For
that we analyzed cell proliferation, numbers of neural stem and progen-
itor cells, as well as cell survival and differentiation, in 12 month-old
S7ΔEx1- andwildtypemice. In addition,we examinedNPC proliferation
ex vivo in neurosphere assays.
2. Material and methods
Four cohorts of mice were used for the study: wild type (WT) and
S7ΔEx1 mice of 4 or 12 months of age (n = 8 within each group, total
of 32 mice in CD1 background). The 4 month-old mice were partially
characterized within a previous report (Krampert et al., 2010). All
experiments were approved by the animal ethic committee (Uppsala
Tingsrätt). 4 and 12 month-old male mice were injected with 50 mg/kg
bodyweight BrdU (Fluka, Germany) once daily for 4 consecutive days.
Four weeks later, animals were deeply anesthetized and perfused
transcardially with 4% paraformaldehyde.
2.1. Immunohistochemistry
Tissue processing and immunostainingwere performed as described
previously (Couillard-Despres et al., 2005). Tissue was cut into 25 μm
sagittal sections. The following primary antibodies were used: rat anti-
BrdU 1:250 (Oxford Biotechnology, UK), goat anti-doublecortin (DCX)
1:200 (Santa Cruz, USA), rabbit anti-glial ﬁbrillary acidic protein
(GFAP) 1:500 (Dako, Germany), mouse anti-Nestin 1:300 (Abcam,
UK), mouse anti-NeuN 1:500 (Chemicon, Germany), goat anti-
proliferating cell nuclear antigen (PCNA) 1:300 (Santa Cruz, USA), rab-
bit anti-phospho Smad2 1:1000 (Millipore, USA), and goat anti-SOX2
1:500 (Santa Cruz, USA). Secondary antibodies were: donkey anti-
goat, -rat or -mouse conjugated with biotin 1:500 (Jackson Immuno
Research, USA). For immunoﬂuorescence co-labeling analysis, donkey
anti-goat Alexa 488, donkey anti-goat or-rat Alexa 568, and donkeyFig. 1 Age-dependent modulation of cell proliferation, cell differentiation, and neurogenesis in
signiﬁcantly increased in 4 month-old S7ΔEx1 mice compared to age-matched WT. In contras
compared to WT animals. (B) Numbers of DCX+ cells do not differ between the 4 month old
a signiﬁcant reduction of DCX+ cells. (C) In the DG of 4 month-old S7ΔEx1 mice, Nestin and S
are signiﬁcantly higher in the SVZ in the young transgenic mice (C″). At 12 months, the num
SVZ. (D) PCNA expressionwithin theNestin+ cell population is decreased in 12month-old S7ΔE
of DCX+ neuronal progenitor cells does not differ between 12month-oldWT and S7ΔEx1mice.
the young transgenic compared toWTmice, but did not differ in the 12month-oldmice. In theD
cell number, was signiﬁcantly higher in the 12 month-old S7ΔEx1 animals compared to the W
differences in the percentage of BrdU double labeled cells in the DG (F′) and the SVZ (F″) betw
signiﬁcantly lower in the S7ΔEx1mice. In addition, independent of their genotype, young mice
(F″) Scale bars: 100 μm.anti-mouse or -rat Alexa 647 (all 1:1000, Molecular Probes, USA) were
used. DAB and immunoﬂuorescence stainings were done as described
(Couillard-Despres et al., 2005). For quantiﬁcation of BrdU-, PCNA-,
DCX-, Nestin- and Sox2-positive cells, every 12th section of one cerebral
hemisphere was selected from eachmouse and processed for immuno-
histochemistry. The volume of the granule cell layer of the DG or the SVZ
was determined by tracing the area using a semiautomatic stereology
system and multiplying with the section thickness and interval
(Stereoinvestigator, MicroBrightField, Colchester, USA). The total
number of labeled cells for the speciﬁc marker was determined on the
selected sections and multiplied by the interval. Results are depicted
as labeled cell densities, i.e. the total number of labeled cells within
each region divided by the regions volume.
To determine the differentiation pattern of newborn cells, every
12th section of one cerebral hemisphere from each mouse was double
stained with BrdU and either Sox2, DCX, NeuN or GFAP, and every
BrdU positive cell detectedwas analyzed using a confocal laser scanning
microscope (LSM 700, Zeiss, Germany). The survival rate of the newly
generated cells in the DGwas obtained by calculating a relative survival
index for all treatment groups. For this, the ratio between the number of
BrdU+ cells (survival) and the number of PCNA+ cells (proliferation)
was calculated.
2.2. In vitro analyses
Adult NPCs were isolated from the SVZ of 4 month and 12 month-
old mice as described (Wachs et al., 2003) and grown in Neurobasal
(NB) medium (Invitrogen) supplemented with B27 (Invitrogen),
2 mM L-glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin
(Sigma, Germany), 2 μg/ml heparin (Sigma), 10 ng/ml FGF-2
(Peprotech, UK) and 20 ng/ml EGF (R&D Systems, UK). Cells were seed-
ed in T-25 culture ﬂasks, grown in suspension cultures at 37 °C in an
incubator with 5% CO2 and passaged weekly. Cells of passage numbers
2 to 6 were used for the present experiments. For proliferation assays,
NPCs were seeded at a density of 104 cells/ml in 24-well plates and
counted after 4 days. To determine the initial number of spheres ob-
tained from hippocampus- and SVZ tissue, we made use of the “neural
colony forming cell assay”-kit (Stem Cell Technologies, Inc., US) accord-
ing to the manufacturer's recommendations. Brieﬂy, cells isolated from
six 12 month-old mice were pooled in 1 ml medium; SVZ-derived cells
(75 μl) or hippocampus-derived cells (200 μl) were suspended in 1.5ml
of a collagen gel and plated into 12-well plates (500 μl/well). Growth
factors were supplemented weekly and spheres were counted after
3 weeks.
2.3. Statistical analysis
Statistical analyses were performed using the GraphPad Prism 4.0
software (GraphPad Software, San Diego, CA, USA). Data were analyzed
by two-way analysis of variance (ANOVA) followed by Bonferroni post
hoc tests when necessary. For comparison of two independent groups,
the Mann Whitney U-test and the Students T-test, respectively,
were performed. p values b0.05 were considered to be statistically
signiﬁcant (*p b 0.05; **p b 0.01; ***p b 0.001). All values were
expressed as means ± standard deviation.S7ΔEx1 mutant mice.(A) Numbers of PCNA+ cells within the DG (A′) and SVZ (A″) are
t, in 12 month-old animals, numbers of PCNA+ cells are signiﬁcantly lower in transgenic
S7ΔEx1 and WT mice in the DG (B′) and the SVZ (B″). At 12 months, S7ΔEx1 mice show
ox2 cell numbers are signiﬁcantly elevated compared to WT (C′), and Sox2 cell numbers
bers of Nestin+ and Sox2+ cells are similar in WT and knockout mice in the DG and the
x1mice compared toWTmice (p= 0.075). In contrast, the proliferative activity (PCNA+)
(E) Numbers of BrdU positive cells in the DG (E′) and SVZ (E″) were signiﬁcantly higher in
G, the survival index of newly generated cells, based on BrdU cell number divided by PCNA
T mice (E‴). (F) Cell fate analyses by BrdU co-labeling with speciﬁc markers revealed no
een old transgenic and WT mice. In young mice, the fraction of BrdU+/NeuN+ cells was
possessed a signiﬁcant higher percentage of BrdU+/Sox2+ cells in the SVZ than agedmice
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We recently reported that young S7ΔEx1 mice (3–4 month old) ex-
hibit enhanced proliferation of NPCs in the DG and the SVZ (Krampert
et al., 2010). In the present report, we made use of this observation
and addressed the possibilities that either the hyperproliferative pheno-
type was maintained during aging or the hyperproliferation of NPCs in
the young animals caused a premature depletion or inactivation of the
stem cell pool. Detection of proliferating NPCs in the DG and SVZ
using the cell cycle marker PCNA (Fig. 1A) revealed that the over-
proliferative phenotype of S7ΔEx1 mice was actually reverted in aged
mice. Hence, in contrast to the young mice, 12 month-old mutant
mice showed reduced proliferation compared to their wildtype coun-
terparts (Fig. 1A). Furthermore, compared to WT mice, old S7ΔEx1
mice also had reduced levels of neurogenesis in the DG and the SVZ,
as revealed by the reduced number of DCX-positive cells, a marker for
newborn neurons (Fig. 1B).
To examine if the reduced proliferation in old S7ΔEx1 animals was a
result of the exhaustion of the stem cell pool due to earlier excessive
proliferation, we determined the numbers of Nestin positive as well as
of Sox2 positive cells (markers for neural stem/progenitor cells) in the
DG and SVZ (Fig. 1C). While in the young S7ΔEx1 animals the numbers
of Nestin and Sox2 positive cells were elevated compared to the WT
animals (for Nestin at least in the dentate gyrus), the numbers of Nestin
and Sox2 positive cells in the aged animals were unaffected by the
genotype in both neurogenic regions (Fig. 1C).
This clearly points toward the presence of a similar number of neural
stem cells in aged S7ΔEx1 andWT animals. However, the percentage of
Nestin positive cells that were proliferating, i.e. PCNA positive, was
slightly reduced in the hippocampi of S7ΔEx1 compared toWT animals
(Fig. 1D, p= 0.075). DCX positive cells, in contrast, were not blocked in
their capacity to proliferate (Fig. 1D).
We next analyzed if the survival and differentiation fate of newborn
cells was changed in aged S7ΔEx1 compared to WT mice. Remarkably,Fig. 2.NPC cultures derived from old S7ΔEx1-mice regain their hyperproliferative activity in vitr
mice plated directly into a collagen gel (A′).While in the 4 month age group the S7ΔEx1-mice e
12month-old S7ΔEx1-mice in respect to age-matchedWTmice (A″). (B) A proliferation assay o
6) revealed increased sphere size (B′) and increased cell numbers (B″) in the S7ΔEx1-mice comp
were higher in 12 month-old S7ΔEx1-mice than in age-matched WT mice (B″). Counting was12 month-old mutant and WT mice showed a comparable number of
BrdU positive cells (i.e. cells that had incorporated BrdU 4 weeks be-
fore) in the DG and SVZ (Fig. 1E). For the DG, considering the decreased
number of newborn (PCNA+) cells in aged transgenic compared to WT
mice at this site (Fig. 1A′), this indicates a signiﬁcant increased survival
of newly generated cells in the S7ΔEx1 animals (Fig. 1E‴). To further
study the fate of newborn cells in the DG, we analyzed the amount of
BrdU co-labeled neural stem cells (BrdU+/Sox2+), neuronal progeni-
tors (BrdU+/DCX+), mature neurons (BrdU+/NeuN+), and astrocytes
(BrdU+/GFAP+). No differences in the percentages of BrdU–Sox2,
BrdU–DCX, BrdU–GFAP or BrdU–NeuN positive cells were found in
12 month-old transgenic compared to WT mice, indicating no changes
on the fate of newborn cells in aged mice (Fig. 1F′). Within the SVZ,
we concentrated on the analysis of BrdU+/Sox2+ and BrdU+/DCX+
cells (Fig. 1F″), since in both aged WT and transgenic animals, the ma-
jority of BrdU positive cells has migrated out of the neurogenic niche
into the olfactory bulb (OB) during the differentiation process (WT:
13.3% BrdU+ cells in the SVZ, 4.3% rostral migratory stream (RMS),
82.4% OB; S7ΔEx1: 15.3% SVZ, 7.4% RMS, 77.3% OB; data not shown).
Again, no differences in the distribution of BrdU co-labeled cells were
found between 12-month transgenic andWTmice. However, indepen-
dent of the genotype, the 4-month old mice possessed a signiﬁcant
higher number of BrdU+/Sox2+ cells compared to 12 month-old
S7ΔEx1 and WTmice (Fig. 1F″), which points toward a higher prolifer-
ative activity of Sox2 positive neural stem cells in young compared to
aged mice.
Next, we wanted to determine if the block in NPCs' proliferation in
the aged S7ΔEx1 animals is of cell-autonomous nature and maintained
in vitro, or whether cells can be released from the proliferation block
and regain their full proliferation potential when taken out of their
niche. Therefore, we performed ex vivo clonal spheres forming assays
as described (Bull and Bartlett, 2005). Dissociated SVZ cells freshly
isolated fromWT and S7ΔEx1mice were plated directly into a collagen
gel to ensure clonal sphere formation that was then quantiﬁed 3 weekso. (A)Quantiﬁcation of primary spheres forming units from the SVZ of 4 and 12month-old
xhibit a signiﬁcant higher number of primary spheres, less spheres could be obtained from
n culturedNPCs derived from the SVZ of 12month-oldWT and S7ΔEx1mice (passages 2–
ared toWTmice. Further, the percentages of NPCs labeledwith the cell-cycle-marker Ki67
performed in triplicates (N300 total cells per sample).
Fig. 3.pSmad2 staining intensity is elevatedwithin the neurogenic regions of 12 month old S7ΔEx1mice. Immunohistochemical staining of pSmad2 ismore intense in the dentate gyrus of
12 month old S7ΔEx1 mice (A) compared to age-matchedWT mice (B). Similarly, pSmad2 staining is more apparent in the SVZ of 12 month old S7ΔEx1 mice (C) compared toWT (D).
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young animals, a lower number of spheres could be obtained from
12 month-old S7ΔEx1-mice in respect to age-matched WT mice
(Fig. 2A″). This may be either because aged S7ΔEx1 mice had a smaller
number of stem/progenitor cells in the neurogenic niche, or because
some of the acutely isolated progenitors still suffered from the inﬂuence
of a putative niche associated proliferation inhibitor and therefore did
not proliferate.
To further investigate the latter assumption, we hypothesized that
after repeated passaging, NPCs from aged S7ΔEx1 mice would be
released from their niche-associated proliferative block. Therefore, we
analyzed growth and expansion of neurospheres after they had been
passaged. Indeed, NPCs isolated from 12 month-old S7ΔEx1 mice
taken in culture and passaged at least once revealed a faster prolifera-
tion compared to cells isolated from wildtype mice. This was evident
based on sphere size (Fig. 2B′), cell counting (Fig. 2B″) and staining for
the cell cycle marker Ki67 (Fig. 2B‴). Together, these observations
argue for a cell-intrinsic mechanism in S7ΔEx1 mice that enhances the
cell-extrinsic and age-associated inhibition in NPC proliferation. Alter-
natively, the reversal of the hyperproliferative phenotype after passag-
ing may also be caused by the in vitro exposure to growth factors,
since it has already been reported for oligodendrocyte precursors, that
growth factors have the capacity to induce chromatin remodeling and
to alter cellular behavior (Kondo and Raff, 2000).
To further address the possibility of a niche-associated inﬂuence, we
examined if in aged mice, in which TGF-beta levels are reported to be
elevated (Pineda et al., 2013), the Smad7ΔEx1 mutation may result in
increased intracellular TGF-beta signaling in the 12 month-old mice.
As an immunohistological indicator for TGF-beta signaling, we made
use of antibodies speciﬁc for the phospho-form of Smad2 (pSmad2)
(Kandasamy et al., 2010). Typically, ligand binding triggers the phos-
phorylation of Smad2, and elevated TGF-beta signaling is reﬂected in
increased intensity of pSmad2 staining. Our results showed that
staining intensity for pSmad2 was indeed increased in the DG and SVZ
of 12 month-old S7ΔEx1 compared to WT mice (Fig. 3).
In summary, these results point toward a TGF-beta dependent
enhanced quiescence of neural stem and progenitor cells in aged
Smad7ΔEx1 mice. At the same time, the survival of newborn cells is
enhanced in Smad7ΔEx1mice compared to wildtypemice. Both effects,
i.e. less proliferation and stem cell quiescence as well as enhanced
survival of newly generated cells are likely to involve elevated TGF-
beta signaling. This is in consistence with our recent study demonstrat-
ing that TGF-beta signaling in the adult neurogenic niche promotes
stem cell quiescence as well as survival of newborn cells (Kandasamy
et al., accepted for publication). Nevertheless, once released from the
niche- and age-associated proliferation inhibition, S7ΔEx1 NPCs regaintheir cell-intrinsic hyperproliferative activity. In addition, the present
study illustrates that a hyperproliferation of NPCs in young age does
not necessarily lead to a premature depletion of the stem cell pool.
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